Literature DB >> 11402634

Pharmacokinetics of metformin gastric-retentive tablets in healthy volunteers.

G Gusler1, J Gorsline, G Levy, S Z Zhang, I E Weston, D Naret, B Berner.   

Abstract

The single-dose pharmacokinetics of two gastric-retentive, extended-release tablet formulations of metformin hydrochloride in fed, healthy volunteers were compared with those of the currently marketed immediate-release metformin hydrochloride product. The plasma concentration-time profiles demonstrated extended-release characteristics from the gastric-retentive tablets. The mean bioavailability from each gastric-retentive tablet was approximately 115%, relative to the immediate-release (IR) product. Cmax values were lower and tmax values were greater for the gastric-retentive tablets compared with the IR product. In contrast to conventional extended-release metformin tablets reported in the literature, these gastric-retentive tablets showed extended-release plasma concentration profiles of metformin hydrochloride and increased bioavailability compared with the immediate-release tablet.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11402634     DOI: 10.1177/00912700122010546

Source DB:  PubMed          Journal:  J Clin Pharmacol        ISSN: 0091-2700            Impact factor:   3.126


  12 in total

Review 1.  Treatment of the metabolic disturbances caused by antipsychotic drugs: focus on potential drug interactions.

Authors:  Trino Baptista; N M K Ng Ying Kin; Serge Beaulieu
Journal:  Clin Pharmacokinet       Date:  2004       Impact factor: 6.447

2.  Steady-state pharmacokinetics of a novel extended-release metformin formulation.

Authors:  Peter Timmins; Steve Donahue; Jeff Meeker; Punit Marathe
Journal:  Clin Pharmacokinet       Date:  2005       Impact factor: 6.447

3.  Intestinal permeability of metformin using single-pass intestinal perfusion in rats.

Authors:  Nai-Ning Song; Quan-Sheng Li; Chang-Xiao Liu
Journal:  World J Gastroenterol       Date:  2006-07-07       Impact factor: 5.742

4.  Prediction of the Effects of Renal Impairment on Clearance for Organic Cation Drugs that Undergo Renal Secretion: A Simulation-Based Study.

Authors:  Kristin E Follman; Marilyn E Morris
Journal:  Drug Metab Dispos       Date:  2018-02-28       Impact factor: 3.922

5.  Relative bioavailability and bioequivalence of metforphin hydrochloride extended-released and immediate-released tablets in healthy Chinese volunteers.

Authors:  Jun Li; Yong Jin; Ting-Yu Wang; Xiong-Wen Lü; Yuan-Hai Li
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2007 Jan-Mar       Impact factor: 2.441

6.  Magnetic resonance imaging for the in vivo evaluation of gastric-retentive tablets.

Authors:  Andreas Steingoetter; Dominik Weishaupt; Patrick Kunz; Karsten Mäder; Hans Lengsfeld; Miriam Thumshirn; Peter Boesiger; Michael Fried; Werner Schwizer
Journal:  Pharm Res       Date:  2003-12       Impact factor: 4.200

7.  Gerosuppressant metformin: less is more.

Authors:  Javier A Menendez; Sílvia Cufí; Cristina Oliveras-Ferraros; Luciano Vellon; Jorge Joven; Alejandro Vazquez-Martin
Journal:  Aging (Albany NY)       Date:  2011-04       Impact factor: 5.682

8.  Gastroretentive behavior of orally administered radiolabeled tamarind seed formulations in rabbits validated by gamma scintigraphy.

Authors:  Mahboubeh Razavi; Hamed Karimian; Chai Hong Yeong; Mehran Fadaeinasab; Si Lay Khaing; Lip Yong Chung; Didi Erwandi B Mohamad Haron; Mohamed Ibrahim Noordin
Journal:  Drug Des Devel Ther       Date:  2016-12-19       Impact factor: 4.162

9.  Development of an oral once-weekly drug delivery system for HIV antiretroviral therapy.

Authors:  Ameya R Kirtane; Omar Abouzid; Daniel Minahan; Taylor Bensel; Alison L Hill; Christian Selinger; Anna Bershteyn; Morgan Craig; Shirley S Mo; Hormoz Mazdiyasni; Cody Cleveland; Jaimie Rogner; Young-Ah Lucy Lee; Lucas Booth; Farhad Javid; Sarah J Wu; Tyler Grant; Andrew M Bellinger; Boris Nikolic; Alison Hayward; Lowell Wood; Philip A Eckhoff; Martin A Nowak; Robert Langer; Giovanni Traverso
Journal:  Nat Commun       Date:  2018-01-09       Impact factor: 14.919

10.  Safety, tolerability, and efficacy of metformin extended-release oral antidiabetic therapy in patients with type 2 diabetes: an observational trial in Asia.

Authors:  Chul-Hee Kim; Kyung-Ah Han; Han-Jin Oh; Kevin Eng-Kiat Tan; Radhakrishna Sothiratnam; Askandar Tjokroprawiro; Marcus Klein
Journal:  J Diabetes       Date:  2012-12       Impact factor: 4.006

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.